MedPath

Evaluating the Efficacy of an Absorbent Foam Dressing Containing Silver (Mepilex Ag) Versus the Same Dressing Without Silver Used on Subjects With Venous Leg Ulcers or Mixed Ulcers

Phase 4
Completed
Conditions
Venous Leg Ulcers
Mixed Leg Ulcers
Interventions
Device: Mepilex Ag
Device: Mepilex without Ag
Registration Number
NCT01036438
Lead Sponsor
Molnlycke Health Care AB
Brief Summary

Compare the efficacy of using an absorbent foam silver dressing (Mepilex Ag) versus the equivalent dressing without silver in subjects suffering from venous leg ulcer or mixed ulcer with an ABPI ≥ 0.8 and with inflammatory signs. Efficacy will be defined as absolute wound size reduction.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
201
Inclusion Criteria
  • Subjects with colonised/ local infection in a venous leg ulcer or mixed leg ulcer with an ABPI ≥ 0,8 and < 1.3

  • A history of an appropriate compression therapy for at least 2 weeks prior to randomisation

  • Subjects with colonised/local infection presenting with three of five following specified signs:

    • pain between dressing changes
    • exuding wounds
    • erythema on peri-wound skin
    • oedema
    • odour
  • An ulcer size of at least 4 cm2 and a maximum size witch could be covered by one investigational product of 15x15 cm.

  • Ulcer duration 6 weeks to 1 year

  • In case of multiple ulcers: target ulcer must be at least 3 cm distant from other ulcers.

  • Both gender with an age ≥ 18 years

  • Signed informed consent

Exclusion Criteria
  • > 10% necrotic (black) or fibrinous (yellow) tissue covering the wound bed
  • Infected wounds in need of systemic antibiotic treatment
  • Use of anti-microbial dressings or topical agents such as antiseptics, local antibiotics and steroids within 7 days from inclusion on the wound intended to be included
  • Previous treatment with silver product 2 weeks prior to inclusion
  • Previous treatment with MepilexAg® on the target ulcer
  • Use of systemic antibiotics for any reason during the previous 7 days
  • Venous surgery 2 weeks prior to inclusion or planned surgery within 8 weeks after inclusion
  • Diagnosed underlying disease(s) (e.g. HIV/AIDS, cancer/malignancy and severe anaemia) judged by the investigator to be a potential interference in the wound evaluation
  • Subjects with poorly controlled diabetes mellitus i.e. HbA1c >8%
  • Subjects treated with systemic immunosuppressive or glucocorticosteroids, except subjects taking occasional doses or doses less than 10mg prednisolon/day or equivalent. Subjects inhaling glucocorticosteroids for asthma should not be excluded.
  • Known allergy/hypersensitivity to any of the components of the investigation products.
  • Subjects with physical and/or mental conditions that are not expected to comply with the investigation due to poor medical condition
  • Participation in other clinical investigation(s) within 1 month prior to start of the investigation.
  • Previously randomised to this investigation.
  • Life expectance of the subject less than 3 months
  • Pregnant or breast-feeding women

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Mepilex AgMepilex Ag-
Mepilex productMepilex without Ag-
Primary Outcome Measures
NameTimeMethod
Efficacy Will be Defined as Absolute Wound Size Reduction.8 weeks

Efficacy will be defined as absolute wound size reduction.

Secondary Outcome Measures
NameTimeMethod
Change in Inflammatory Signs4 weeks

Change in inflammatory signs

Trial Locations

Locations (44)

Dermatology Department, University Hospital, Hopital Sud

🇫🇷

Amiens cedex, France

Nemocnice Podlesí a.s.

🇨🇿

Třinec, Czech Republic

Krajská nemocnice Liberec

🇨🇿

Liberec, Czech Republic

Uherskohradišťská nemocnice a. s.

🇨🇿

Uherské Hradiště, Czech Republic

CHU Le Bocage Service Dermatologie

🇫🇷

Dijon Cedex, France

Hôpital Saint Joseph

🇫🇷

Paris, France

APHP Hôpital Lariboisère

🇫🇷

Paris, France

CHG La Roche-sur-Yon Service de D'Angiologie,Les Oudairies

🇫🇷

La Roche-sur-Yon, France

Hôpital Saint Jacques - CHU Besançon

🇫🇷

Besançon, France

Résidence le Bristol

🇫🇷

Boulogne-sur-mer, France

Fakultní nemocnice Na Bulovce

🇨🇿

Prague, Czech Republic

Service de Dermatologie, Centre Hospitalier Regional Universitaire

🇫🇷

Caen cedex 9, France

Hôpital privé d'Antony Service de Dermatologie

🇫🇷

Antony, France

Centre Hospitalier le Mans Service de Dermatologie

🇫🇷

Le Mans cedex 9, France

Cabinet D'Angeiologie

🇫🇷

Lille, France

Hopital Maringer-Villemin- Fournier

🇫🇷

Nancy, France

Pharmacie Centrale-Service Arsenal

🇫🇷

Nantes, France

Clinique Pasteur

🇫🇷

Toulouse, France

Universtätsmedizin Charité Klinik für Dermatologie, Allergologie und Venerologie

🇩🇪

Berlin, Germany

Maison de Santé Protestante de Bordeaux-Bagatelle

🇫🇷

Talence Cedex, France

Polyclinique de Picardie Service d'Angiologie Phlébologie

🇫🇷

Amiens, France

Hôpital Albert Michallon Service de médecine vasculaire

🇫🇷

Grenoble Cedex 9, France

Hopital Robert Debré Service de Dermatologie

🇫🇷

Reims, France

Hôpital Rotchild - Jean Rostand

🇫🇷

Paris, France

Hopital Beauregard / Secrétariat de Dermatologie

🇫🇷

Thionville, France

St. Antonius Ziekenhuis

🇳🇱

Utrecht, Netherlands

Bramfelder Chaussee 200

🇩🇪

Hamburg, Germany

University Hospital Regensburg

🇩🇪

Regensburg, Germany

Venenzentrum der Dermatologischen und Gefäßchirurgischen Kliniken -

🇩🇪

Bochum, Germany

Universität klinikum Jena, Klinik für dermatologie und dermatologische

🇩🇪

Jena, Germany

Dermatology department

🇳🇱

Amsterdam, Netherlands

Nemocnice Jihlava

🇨🇿

Jihlava, Czech Republic

Fakultní nemocnice U svate Anny, St. Anne´s University Hospital

🇨🇿

Brno, Czech Republic

Dermatovenerologická klinika, University Hospital Bohunice,

🇨🇿

Brno, Czech Republic

Dermatovenerologická klinike, Univerzita Karlova

🇨🇿

Plzen, Czech Republic

Masarykova Hospital, Dermatology dept.

🇨🇿

Usti nad Labem, Czech Republic

Dermatovenerologie Rendlová s.r.o.

🇨🇿

České Budějovice, Czech Republic

Cabinet d'Angiologie, 1 bis rue de Salgareda

🇫🇷

St Alban, France

Universitätsklinikum Hamburg-Eppedorf

🇩🇪

Hamburg, Germany

Universitäts-Hautklinik

🇩🇪

Tübingen, Germany

Hopital Charles Nicolle

🇫🇷

Rouen cedex, France

Service de dermatologie

🇫🇷

Toulon cedex, France

Universitätsklinikum Schleswig-Holstein Campus Lübeck

🇩🇪

Lübeck, Germany

chirugické oddělení, Fakultní nemocnice Královské Vinohrady

🇨🇿

Praha, Czech Republic

© Copyright 2025. All Rights Reserved by MedPath